Table 3.

Mortality associated with race/ethnicity in men with prostate carcinoma by SEER Summary stage at diagnosis, 1995–2002

	Adjusted Hazard Ratio (95% CI) for Mortality
	** Overall	* Localized Stage	* Regional/Distant Stage	* Unknown Stage
Race/ethnicity
Non-Hispanic White	1.00 REF	1.00 REF	1.00 REF	1.00 REF
Non-Hispanic Black	1.36 (1.30–1.42)	1.28 (1.19–1.36)	1.49 (1.37–1.63)	1.35 (1.25–1.46)
Hispanic	0.96 (.92–1.00)	0.93 (0.87–1.00)	1.02 (0.93–1.12)	0.95 (0.88–1.03)
Asian/Pacific Islander	0.65 (0.52–0.82)	0.49 (0.33–0.73)	0.76 (0.51–1.14)	0.83 (0.56–1.24)
SES
Very high SES	1.00 REF	1.00 REF	1.00 REF	1.00 REF
High SES	1.16 (1.11–1.21)	1.14 (1.07–1.22)	1.26 (1.14–1.39)	1.11 (1.02–1.20)
Mid SES	1.22 (1.17–1.28)	1.28 (1.20–1.37)	1.19 (1.07–1.32)	1.16 (1.06–1.26)
Low SES	1.35 (1.28–1.41)	1.41 (1.31–1.51)	1.33 (1.20–1.48)	1.24 (1.13–1.35)
Very low SES	1.34 (1.28–1.41)	1.43 (1.33–1.54)	1.34 (1.20–1.49)	1.18 (1.08–1.30)
Age	1.083 (1.081–1.085)	1.095 (1.092–1.098)	1.067 (1.063–1.071	1.072 (1.069–1.076)
Tumor Grade
Well differentiated	1.00 REF	1.00 REF	1.00 REF	1.00 REF
Moderately differentiated	0.94 (.89–1.00)	0.98 (0.92–1.05)	0.98 (0.78–1.22)	1.00 (0.88–1.13)
Poorly differentiated	1.44 (1.35–1.53)	1.33 (1.23–1.44)	1.86 (1.49–2.32)	1.79 (1.58–2.04)
Undifferentiated	2.10 (1.86–2.39)	1.75 (1.40–2.19)	2.82 (2.16–3.69)	2.87 (2.24–3.68)
Unknown/Missing	1.65 (1.55–1.76)	1.15 (1.04–1.26)	3.20 (2.56–4.01)	1.83 (1.62–2.06)
Rural Residence
Urban	1.00 REF	1.00 REF	1.00 REF	1.00 REF
Large Town	1.02 (0.97–1.06)	1.02 (0.95–1.09)	1.07 (0.97–1.18)	1.00 (0.92–1.08)
Small Town	1.06 (0.99–1.13)	1.03 (0.94–1.14)	1.06 (0.92–1.21)	1.09 (0.98–1.20)
Rural	0.99 (0.92–1.10)	0.94 (0.81–1.09)	0.98 (0.80–1.21)	1.05 (0.90–1.23)

^**Adjusted for stage and year of diagnosis

^*Adjusted for year of diagnosis

^#Socioeconomic status (SES) is based on a census-derived composite index with quintiles ranging from very high to very low.